99 related articles for article (PubMed ID: 578286)
21. [Bromocriptine in the treatment of Parkinson's disease].
Sepcić J; Ledić P
Neurologija; 1982; 30(1-4):75-81. PubMed ID: 6765062
[No Abstract] [Full Text] [Related]
22. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Ulm G
Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
[No Abstract] [Full Text] [Related]
23. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Riopelle RJ; Gawel MJ; Libman I; King DB; McLean DR; Paulseth R; Raphy B; Bouchard S
Eur Neurol; 1988; 28 Suppl 1():11-4. PubMed ID: 3288477
[TBL] [Abstract][Full Text] [Related]
24. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
25. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
Rascol A; Montastruc JL; Guiraud-Chaumeil B; Clanet M
Rev Neurol (Paris); 1982; 138(5):401-8. PubMed ID: 7146724
[TBL] [Abstract][Full Text] [Related]
26. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
[No Abstract] [Full Text] [Related]
27. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
28. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
Todman DH; Oliver WA; Edwards RL
Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
[TBL] [Abstract][Full Text] [Related]
29. Low-dose bromocriptine in the early phases of Parkinson's disease.
Tolosa E; Blesa R; Bayes A; Forcadell F
Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610
[TBL] [Abstract][Full Text] [Related]
30. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
Stern GM; Lees AJ
Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
[TBL] [Abstract][Full Text] [Related]
31. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
32. Parenteral administration of lisuride in Parkinson's disease.
Luquin MR; Obeso JA; Martínez-Lage JM; Tresguerres J; Parada J; Nieuweboer B; Dorow R; Horowski R
Adv Neurol; 1987; 45():561-8. PubMed ID: 3825733
[No Abstract] [Full Text] [Related]
33. Developments in the treatment of parkinsonism.
Calne DB
N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
[No Abstract] [Full Text] [Related]
34. The use of lisuride in severe Parkinson's disease.
Chin D; Yu YL; Huang CY
Clin Exp Neurol; 1986; 22():63-9. PubMed ID: 3581512
[TBL] [Abstract][Full Text] [Related]
35. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
Godwin-Austen RB
Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
[No Abstract] [Full Text] [Related]
36. Bromocriptine mesylate in Parkinson's disease.
Lieberman A; Kupersmith M; Neophytides A; Casson I; Durso R; Foo SH; Khayali M; Tartaro T
N Y State J Med; 1979 Oct; 79(11):1689-92. PubMed ID: 290866
[No Abstract] [Full Text] [Related]
37. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri SA
Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057
[No Abstract] [Full Text] [Related]
38. Letter: Bromocriptine in parkinsonism.
Debono AG; Donaldson I; Marsden CD; Parkes JD
Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
[No Abstract] [Full Text] [Related]
39. Evaluation of terguride in patients with Parkinson's disease.
Suchy I; Rinne UK; Wachtel H
Adv Neurol; 1987; 45():577-81. PubMed ID: 3548267
[No Abstract] [Full Text] [Related]
40. [Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years].
Montastruc JL; Rascol O; Rascol A
Therapie; 1988; 43(6):461-3. PubMed ID: 3227512
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
